Increased ocular lens density in HIV-infected individuals with low nadir CD4 counts in South Africa: Evidence of accelerated aging

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue 3, 2013, Pages 307-314

  Pathai, Sophia ^a,b   Lawn, Stephen D ^a,b   Weiss, Helen A ^a   Cook, Colin ^c   Bekker, Linda Gail ^b   Gilbert, Clare E ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Aging; Cataract; HIV; Lens density; Pentacam

Indexed keywords

ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER;

ADULT; AGING; ARTICLE; BLINKING; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DENSITOMETRY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMAGE QUALITY; LENS DENSITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOUTH AFRICA; THERAPY; TREATMENT DURATION; VIREMIA; VIRUS DETECTION; VIRUS LOAD; VISUAL SYSTEM PARAMETERS;

ADULT; AGING; AGING, PREMATURE; ANTI-HIV AGENTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CATARACT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DENSITOMETRY; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; SOUTH AFRICA; VIRAL LOAD;

EID: 84880237729     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31828ad759     Document Type: Article

References (43)

1. Mocroft A, Brettle R, Kirk O, et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS. 2002;16:1663-1671.
2. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996- 2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010; 50: 1387-1396.
3. CDC. HIV/AIDS among persons aged 50 or over. Available at: http://www.cdc.gov/hiv/surveillance/resources/reports/2005report/. Accessed October 1, 2012.
4. Awofeso N, Rammohan A. AIDS and elderly people. Elderly Africans have AIDS too. BMJ. 2010;341:c4169.
5. Mills EJ, Bärnighausen T, Negin J. HIV and aging-preparing for the challenges ahead. N Engl J Med. 2012;366:1270-1273.
6. Deeks SG. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med. 2009;17: 118-123.
7. Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med. 2007; 146:87-95.
8. Effros RB, Fletcher CV, Gebo K, et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis. 2008;47:542-553.
9. Rasmussen LD, Engsig FN, Christensen H, et al. Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study. AIDS. 2011;25:1637-1646.
10. Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbid-ities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53:1120-1126.
11. Phillips AN, Neaton J, Lundgren JD. The role of HIV in serious diseases other than AIDS. AIDS. 2008;22:2409-2418.
12. Capeau J. Premature aging and premature age-related comorbidities in HIV-infected patients: facts and hypotheses. Clin Infect Dis. 2011;53: 1127-1129.
13. Hodge WG, Whitcher JP, Satariano W. Risk factors for age-related cataracts. Epidemiol Rev. 1995;17:336-346.
14. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96:614-618.
15. Hennis A, Wu SY, Li X, et al. Lens opacities and mortality: the Barbados Eye Studies. Ophthalmology. 2001;108:498-504.
16. West SK, Munoz B, Istre J, et al. Mixed lens opacities and subsequent mortality. Arch Ophthalmol. 2000;118:393-397.
17. Truscott RJ, Zhu X. Presbyopia and cataract: a question of heat and time. Prog Retin Eye Res. 2010;29:487-499.
18. Truscott RJW. Are ancient proteins responsible for the age-related decline in health and fitness? Rejuvenation Res. 2010;13:83-89.
19. Eldred JA, Dawes LJ, Wormstone IM. The lens as a model for fibrotic disease. Philos Trans R Soc Lond B Biol Sci. 2011;366:1301-1319.
20. Wormstone IM, Wride MA. The ocular lens: a classic model for development, physiology and disease. Philos Trans R Soc Lond B Biol Sci. 2011;366:1190-1192.
21. Jabs DA. Cytomegalovirus retinitis and the acquired immunodeficiency syndrome-bench to bedside: LXVII Edward Jackson Memorial Lecture. Am J Ophthalmol. 2011;151:198-216.e1.
22. Lawn SD, French MA. Immune reconstitution disease: recent developments and implications for antiretroviral treatment in resource-limited settings. Curr Opin HIV AIDS. 2007;2:339-345.
23. Goldberg DE, Wang H, Azen SP, et al. Long term visual outcome of patients with cytomegalovirus retinitis treated with highly active antire-troviral therapy. Br J Ophthalmol. 2003;87:853-855.
24. Pei X, Bao Y, Chen Y, et al. Correlation of lens density measured using the Pentacam Scheimpflug system with the Lens Opacities Classification System III grading score and visual acuity in age-related nuclear cataract. Br J Ophthalmol. 2008;92:1471-1475.
25. Kirkwood BJ, Hendicott PL, Read SA, et al. Repeatability and validity of lens densitometry measured with Scheimpflug imaging. J Cataract Refract Surg. 2009;35:1210-1215.
26. High KP, Brennan-Ing M, Clifford DB, et al. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012;60:S1-S18.
27. Lawn SD, Myer L, Bekker LG, et al. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS. 2006;20:1605-1612.
28. Lawn SD, Myer L, Orrell C, et al. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS. 2005;19:2141-2148.
29. Pathai S, Gilbert C, Weiss HA, et al. Frailty in HIV-infected adults in South Africa. J Acquir Immune Defic Syndr. 2013;62:43-51.
30. Abdull MM, Sivasubramaniam S, Murthy GV, et al. Causes of blindness and visual impairment in Nigeria: the Nigeria national blindness and visual impairment survey. Invest Ophthalmol Vis Sci. 2009;50:4114-4120.
31. Pathai S, Weiss HA, Lawn SD, et al. Retinal arterioles narrow with increasing duration of anti-retroviral therapy in HIV infection: a novel estimator of vascular risk in HIV? PLoS One. 2012;7:e51405.
32. Goulet JL, Fultz SL, Rimland D, et al. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis. 2007;45:1593-1601.
33. Babiker AG, Emery S, Fätkenheuer G, et al. Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study. Clin Trials. 2013;10(suppl 1):S5-S36.
34. Maman D, Pujades-Rodriguez M, Nicholas S, et al. Response to antire-troviral therapy: improved survival associated with CD4 above 500 cells/ml. AIDS. 2012;26:1393-1398.
35. Rasmussen LD, Kessel L, Molander LD, et al. Risk of cataract surgery in HIV-infected individuals: a Danish nationwide population-based cohort study. Clin Infect Dis. 2011;53:1156-1163.
36. Baker JV, Henry WK, Neaton JD. The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms. Curr Opin HIV AIDS. 2009;4:176-182.
37. Fisher M, Cooper V. HIV and ageing: premature ageing or premature conclusions? Curr Opin Infect Dis. 1 2012;25:1-3.
38. Martin J, Volberding P. HIV and premature aging: a field still in its infancy. Ann Intern Med. 2010;153:477-479.
39. Sanders JL, Iannaccone A, Boudreau RM, et al. The association of cataract with leukocyte telomere length in older adults: defining a new marker of aging. J Gerontol A Biol Sci Med Sci. 2011;66A: 639-645.
40. Chylack LT Jr, Wolfe JK, Singer DM, et al. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993;111:831-836.
41. Pathai S, Gilbert C, Weiss HA, et al. Differing spectrum of HIV-associated ophthalmic disease among patients starting antiretroviral therapy in India and South Africa. Trop Med Int Health. 2011;16:356-359.
42. Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ. 2009;338:a3172.
43. Ye J, He J, Wang C, et al. Smoking and risk of age-related cataract: a meta-analysis. Invest Ophthalmol Vis Sci. 2012;53:3885-3895.